BioLineRx (BLRX) Interest Expenses (2023 - 2025)
Historic Interest Expenses for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to -$304000.0.
- BioLineRx's Interest Expenses rose 8129.23% to -$304000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.4 million, marking a year-over-year decrease of 2684.34%. This contributed to the annual value of -$9.1 million for FY2024, which is 32042.42% down from last year.
- Per BioLineRx's latest filing, its Interest Expenses stood at -$304000.0 for Q3 2025, which was up 8129.23% from -$276000.0 recorded in Q2 2025.
- BioLineRx's Interest Expenses' 5-year high stood at -$276000.0 during Q2 2025, with a 5-year trough of -$10.4 million in Q4 2024.
- In the last 3 years, BioLineRx's Interest Expenses had a median value of -$929000.0 in 2024 and averaged -$2.1 million.
- Its Interest Expenses has fluctuated over the past 5 years, first plummeted by 13941.0% in 2024, then surged by 8676.26% in 2025.
- Quarter analysis of 3 years shows BioLineRx's Interest Expenses stood at -$4.3 million in 2023, then crashed by 139.41% to -$10.4 million in 2024, then surged by 97.07% to -$304000.0 in 2025.
- Its Interest Expenses stands at -$304000.0 for Q3 2025, versus -$276000.0 for Q2 2025 and -$420000.0 for Q1 2025.